SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-21-001656
Filing Date
2021-01-22
Accepted
2021-01-22 16:38:55
Documents
89
Period of Report
2020-10-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm 10-K 1285793
2 ex4-9.htm EX-4.9 54510
3 ex23-1.htm EX-23.1 4357
4 ex31-1.htm EX-31.1 20303
5 ex31-2.htm EX-31.2 20582
6 ex32-1.htm EX-32.1 6719
7 ex32-2.htm EX-32.2 6836
8 chart_001.jpg GRAPHIC 19752
  Complete submission text file 0001493152-21-001656.txt   5685271

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE adxs-20201031.xml EX-101.INS 821632
10 XBRL SCHEMA FILE adxs-20201031.xsd EX-101.SCH 63908
11 XBRL CALCULATION FILE adxs-20201031_cal.xml EX-101.CAL 91307
12 XBRL DEFINITION FILE adxs-20201031_def.xml EX-101.DEF 214335
13 XBRL LABEL FILE adxs-20201031_lab.xml EX-101.LAB 470003
14 XBRL PRESENTATION FILE adxs-20201031_pre.xml EX-101.PRE 366041
Mailing Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540
Business Address 305 COLLEGE ROAD EAST PRINCETON, NJ 08540 732 545 1590
Advaxis, Inc. (Filer) CIK: 0001100397 (see all company filings)

IRS No.: 841521955 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-36138 | Film No.: 21546326
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences